Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -67,593 | -36,761 | -116,835 | -98,688 | -96,749 |
| Depreciation Amortization | 20,062 | 19,846 | 18,523 | 18,435 | 14,156 |
| Accounts receivable | -5,020 | 52,596 | 2,252 | -3,187 | -13,091 |
| Accounts payable and accrued liabilities | -3,259 | 2,055 | -6,305 | 3,247 | 177 |
| Other Working Capital | -41,593 | 53,665 | 48,858 | -5,723 | -12,297 |
| Other Operating Activity | 58,002 | -68,412 | 28,761 | -1,528 | 3,242 |
| Operating Cash Flow | $-39,401 | $22,989 | $-24,746 | $-87,444 | $-104,562 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -26,108 | -98,962 | -13,363 | N/A | 15,000 |
| PPE Investments | -2,360 | -2,583 | -1,073 | -2,431 | -18,543 |
| Net Acquisitions | N/A | N/A | 79 | -446 | 10,979 |
| Purchase Of Investment | N/A | -2 | 489 | 126 | -143 |
| Sale Of Investment | 158 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -1,173 | -1,260 | N/A | -10 | -13 |
| Other Investing Activity | -1,174 | -1,261 | -1,642 | -10 | -14 |
| Investing Cash Flow | $-29,484 | $-102,808 | $-15,510 | $-2,761 | $7,279 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 23,201 | 29,671 | 5,750 | N/A |
| Debt Repayment | -5,379 | -5,001 | -5,107 | -1,343 | N/A |
| Common Stock Issued | 44 | 82,822 | 67,936 | -569 | 56,239 |
| Other Financing Activity | -11,426 | -11,909 | -9,635 | -2,693 | -8,714 |
| Financing Cash Flow | $-16,761 | $89,113 | $82,865 | $1,145 | $47,525 |
| Exchange Rate Effect | 3,928 | -2,752 | 884 | -3,360 | -5,754 |
| Beginning Cash Position | 143,251 | 136,708 | 93,216 | 185,636 | 241,148 |
| End Cash Position | 61,533 | 143,251 | 136,708 | 93,216 | 185,636 |
| Net Cash Flow | $-81,718 | $6,543 | $43,492 | $-92,420 | $-55,512 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,401 | 22,989 | -24,746 | -87,444 | -104,562 |
| Capital Expenditure | -2,360 | -2,583 | -1,073 | -2,431 | -18,543 |
| Free Cash Flow | -41,761 | 20,406 | -25,819 | -89,875 | -123,105 |